OPA3
Basic information
Region (hg38): 19:45527767-45602212
Links
Phenotypes
GenCC
Source:
- 3-methylglutaconic aciduria type 3 (Definitive), mode of inheritance: AR
- optic atrophy 3 (Supportive), mode of inheritance: AD
- 3-methylglutaconic aciduria type 3 (Supportive), mode of inheritance: AR
- 3-methylglutaconic aciduria type 3 (Strong), mode of inheritance: AR
- optic atrophy 3 (Strong), mode of inheritance: AD
- 3-methylglutaconic aciduria type 3 (Definitive), mode of inheritance: AR
- optic atrophy 3 (Definitive), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
3-methylglutaconic aciduria, type III; Optic atrophy 3, autosomal dominant | AD/AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Biochemical; Neurologic; Ophthalmologic | 2494568; 7510656; 11668429; 12126933; 15342707; 22776096; 23700088; 24749080; 26190011 |
ClinVar
This is a list of variants' phenotypes submitted to
- 3-Methylglutaconic_aciduria_type_3 (327 variants)
- Optic_atrophy_3 (296 variants)
- not_provided (46 variants)
- Inborn_genetic_diseases (19 variants)
- not_specified (11 variants)
- OPA3-related_disorder (11 variants)
- 3-Methylglutaconic_aciduria (1 variants)
- Optic_atrophy (1 variants)
- Achromatopsia (1 variants)
- Foveal_hypoplasia (1 variants)
- See_cases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the OPA3 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000025136.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 117 | 118 | ||||
missense | 141 | 154 | ||||
nonsense | 13 | |||||
start loss | 1 | 1 | ||||
frameshift | 17 | |||||
splice donor/acceptor (+/-2bp) | 4 | |||||
Total | 9 | 25 | 152 | 121 | 0 |
Highest pathogenic variant AF is 0.0000131399
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
OPA3 | protein_coding | protein_coding | ENST00000323060 | 2 | 74786 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.566 | 0.391 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.0520 | 109 | 111 | 0.986 | 0.00000570 | 1144 |
Missense in Polyphen | 43 | 35.898 | 1.1978 | 399 | ||
Synonymous | 0.122 | 51 | 52.1 | 0.978 | 0.00000285 | 393 |
Loss of Function | 1.48 | 0 | 2.54 | 0.00 | 1.21e-7 | 26 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May play some role in mitochondrial processes.;
- Disease
- DISEASE: Optic atrophy 3 (OPA3) [MIM:165300]: A condition that features progressive visual loss in association with optic atrophy. Atrophy of the optic disk indicates a deficiency in the number of nerve fibers which arise in the retina and converge to form the optic disk, optic nerve, optic chiasm and optic tracts. OPA3 is associated with cataract and a neurologic disorder characterized by extrapyramidal signs and ataxia. {ECO:0000269|PubMed:15342707}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.158
Intolerance Scores
- loftool
- 0.318
- rvis_EVS
- 0.37
- rvis_percentile_EVS
- 75.12
Haploinsufficiency Scores
- pHI
- 0.139
- hipred
- N
- hipred_score
- 0.323
- ghis
- 0.496
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.343
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Opa3
- Phenotype
- growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); muscle phenotype; craniofacial phenotype; cellular phenotype; homeostasis/metabolism phenotype; skeleton phenotype; liver/biliary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype;
Gene ontology
- Biological process
- visual perception;regulation of lipid metabolic process;regulation of growth;response to stimulus;neuromuscular process;mitochondrion morphogenesis
- Cellular component
- mitochondrion
- Molecular function